GLP-1 medicines before surgery: what to tell the anesthesia team
Medical Disclaimer: General education, not personal medical advice. No named licensed clinical reviewer has reviewed this article. Full disclaimer. See our affiliate disclosure.
Tell the anesthesia and procedural team about GLP-1 use early. Current multisociety guidance calls for an individualized plan rather than a blanket stop rule.
At a glance
- Many patients can continue treatment under the team’s plan.
- Dose escalation and significant gastrointestinal symptoms can change the risk assessment.
- Follow the procedure team’s fasting and medication instructions.
Why the medicine matters to anesthesia
Delayed gastric emptying can affect the risk of aspiration during general anesthesia or deep sedation. The team needs the exact product, dose, recent changes and any nausea, vomiting or other gastrointestinal symptoms.
Do not keep taking a medicine because a general article says everyone can continue, and do not stop it independently because another article gives a universal week-long rule.
Sources: ASA: multisociety GLP-1 surgery guidanceWegovy prescribing informationZepbound prescribing information
The plan should fit the patient and procedure
ASA’s October 2024 multisociety guidance describes continuation for many patients and additional precautions for higher-risk situations. These can include dietary measures or a change in procedure planning, determined by the treating team.
Ask how the underlying condition will be managed if treatment is interrupted and how restarting will be handled afterward.
Sources: ASA: multisociety GLP-1 surgery guidanceWegovy prescribing informationZepbound prescribing information
Sources and review boundaries
Source check dates are listed below. First-party pages support descriptions of a service’s public offer; medical references support the educational context. They do not establish an independent clinical audit of a provider. This is general education, not personal medical advice; no named licensed clinical reviewer has reviewed this article.
- ASA: multisociety GLP-1 surgery guidanceMedical or regulatory source · Source reviewed ·
- Wegovy prescribing informationMedical or regulatory source · Source reviewed ·
- Zepbound prescribing informationMedical or regulatory source · Source reviewed ·
Related Articles
- What to do when a GLP-1 shipment arrives warm
- Alcohol on semaglutide: risks and questions for your prescriber
- Alcohol on tirzepatide: risks and questions for your prescriber
- Semaglutide compounding pharmacies: sourcing, rules and open questions
- Tirzepatide compounding pharmacies: sourcing, rules and open questions
- Choosing Alternatives If You Cannot Take a GLP-1
By Chief Medical Correspondent. Published . Updates are recorded when content changes.